Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prajnan Das

Showing results (241-250 of 324) with videos related to

Pageof 33
Sort By:
Cancers|April 23, 2022
Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular CarcinomaGohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
Oncotarget|June 4, 2021
CEA as a blood-based biomarker in anal cancerRobert Hester, Shailesh Advani, Asif Rashid, et al.
American Journal of Clinical Oncology|September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal CancerSuzanne Russo, A William Blackstock, Joseph M Herman, et al.
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2021
Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image GuidanceJoshua S Niedzielski, Yufei Liu, Sylvia S W Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Pageof 33

Showing results (241-250 of 324) with videos related to

Sort By:
Pageof 33
Cancers|April 23, 2022
Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular CarcinomaGohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
Oncotarget|June 4, 2021
CEA as a blood-based biomarker in anal cancerRobert Hester, Shailesh Advani, Asif Rashid, et al.
American Journal of Clinical Oncology|September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal CancerSuzanne Russo, A William Blackstock, Joseph M Herman, et al.
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2021
Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image GuidanceJoshua S Niedzielski, Yufei Liu, Sylvia S W Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Pageof 33